CXCL10 and Behcet disease: No differences were found in BD patients classified on BDCAF scores (Table S4), while the classification according to presence/absence of therapy revealed a higher concentration of IP-10 in plasma of BD patients without therapy in comparison to patients under therapy: 835.5 pg/mL (IQR: 570.7–1398 pg/mL) vs. 446.3 pg/mL (IQR: 297.6–676.1 pg/mL), P = 0.0023.